Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy

NCT05076838 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Diazepam Nasal Spray [Valtoco]

Sponsor

Neurelis, Inc.